The in vitro activity of biapenem, a new carbapenem previously designated L-627, was 
During the past several years, a number of extendedspectrum antimicrobial agents have been developed, including penicillins, cephalosporins, and more recently, the carbapenems. Currently, imipenem is the only carbapenem available for clinical use and offers a broad range of activity against both gram-positive and gram-negative aerobic, facultative, and anaerobic organisms (6) . This agent offers an alternative for many gram-negative isolates which are resistant to other beta-lactam antibiotics but has limited activity against methicillin-resistant staphylococci, most Enterococcus faecium strains, and Xanthomonas maltophilia.
Biapenem (previously designated L-627) is a new carbapenem antimicrobial agent with a spectrum of activity similar to that of imipenem (1, 9, 10) . The purpose of this study was to examine the in vitro activity of biapenem against a variety of gram-positive and gram-negative clinical bacterial isolates, including organisms specifically collected for resistance to vancomycin or to various beta-lactam antibiotics.
(This work was presented in part at the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, Calif., 11 to 14 October 1992 [5a].)
Most of the 771 bacterial isolates were obtained from clinical specimens at the Massachusetts General and New England Deaconess hospitals, Boston, Mass. Strains of streptococci and enterococci resistant to beta-lactams were collected from various sources in the United States and elsewhere (2) . Almost all vancomycin-resistant enterococci were referred from hospitals in the northeast United States and in Madrid, Spain (2). Gram-negative facultative bacteria resistant to cefoperazone were collected as part of an earlier study (3 ,ug/ml), and all strains of X. maltophilia were fully resistant to both drugs (MIC range > 64 ,g/ml). H. influenzae and N. gonorrhoeae were equally susceptible to both carbapenems (MIC90s < 2 p,g/ml). Biapenem inhibited all strains of B.
fragilis at concentrations of c 1 ,g/ml, as did imipenem.
The in vitro susceptibilities to biapenem of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Citrobacter freundii isolates selected for resistance to cefoperazone are shown in Table 2 . Except for the MIC90 for E. cloacae, MIC90s were comparable to those for the routine isolates shown in Table 1 . Biapenem remained twofold more active than imipenem against cefoperazone-resistant strains of P. aeruginosa; however, MICs of both drugs were substantially higher than those against cefoperazone-susceptible strains.
Biapenem was found to be active against a broad range of gram-positive and gram-negative aerobic and facultative clinical bacterial isolates and against B. fragilis. In previous investigations, biapenem was shown to be somewhat more active in vitro than imipenem against most members of the family Enterobacteriaceae and P. aeruginosa (1, 9, 10) . Our study confirmed these observations and also found that the susceptibility to biapenem was retained when tested against gram-negative bacilli, such as E. coli and K pneumoniae, which were selected for their resistance to cefoperazone. This can be explained by the stability of this agent against degradation by a broad range of ,-lactamases (10) . Of note was the significantly greater in vitro activity of biapenem against A. hydrophilia, an organism shown to possess a P-lactamase metalloenzyme inducible upon exposure to subinhibitory concentrations of either cefoxitin or imipenem (4) .
The in vitro activity of biapenem against B. fragilis was found to be equivalent to that of metronidazole and twofold greater than that of imipenem, which was consistent with results obtained in most other investigations (5, 8, 9, 10) . Only Catchpole et al. (1) found this agent to be twofold less active than imipenem against this species. Biapenem had activity against many gram-positive isolates, though slightly less than that observed with imipenem. Methicillin-resistant S. aureus and E. faecium were notably more resistant to both carbapenems.
In summary, biapenem was comparable in activity to 
